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Together, these findings have sev-
eral interesting implications. They
demonstrate a coordinate regulation
of metabolic adaptation to amino
acid starvation that impacts not only
protein biosynthetic pathways but
also lipid metabolism. They also
strongly implicate GCN2 as a major
mediator of nutrient sensing via its
ability to detect uncharged tRNAs.
This coupling of pathways provides
for a coordinated response of the or-
ganism to conditions of amino acid
limitation.
Naturally, these surprising observa-
tions raise many questions. Most nota-
bly, what is the molecular pathway by
which GCN2 activation leads to the
repression of hepatic lipogenesis and
mobilization of adipose triglycerides?
Given its ability to stimulate translation
of selected mRNAs, a simple model
would be that GCN2 enhances expres-
sion of a repressor of Srebp-1c gene
expression. Another question is
whether the actions of GCN2 on adi-
pose tissue lipolysis are direct or are
a consequence of metabolic signals
from the liver. It will be interesting to
see how this pathway unravels in fur-
ther extending our understanding of
metabolic adaptations to nutritional
stresses.
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Glycerol-3-phosphate acyltransferase (GPAT) initiates the synthesis of triacylglycerol and phospho-
lipids and, in the process, regulates the formation of several lipid metabolites known to be intracel-
lular signaling molecules. The recent identification of a new GPAT isoform (Cao et al., 2006) suggests
a role for GPAT isoforms in nutrient-mediated signaling.In the pathways of carbohydrate,
amino acid, and protein synthesis, it
is rare to find that more than a single
enzyme catalyzes a specific reaction;
with complex lipid synthesis, however,
the reverse is true. For example, in the
pathway of glycerolipid synthesis out-
lined in the 1950s and 60s by Eugene
Kennedy and colleagues (Kennedy,
1957), every step is catalyzed by two
or more isoforms, each encoded by
a separate gene (Figure 1). Although
the most prominent isoforms may dif-
fer across tissues, most tissues ex-
press at least two of these isoforms.
With the exception of lipin, each en-
zyme in this pathway is an intrinsicmembrane protein containing trans-
membranedomains and long stretches
of hydrophobic amino acids that prob-
ably interact closely with both their hy-
drophobic substrates and the mem-
brane surface. Despite the fact that
the catalytic site of each enzyme
involved in triacylglycerol (TAG) syn-
thesis faces the cytosol, evidence sug-
gests that the lipid intermediates lyso-
phosphatidic acid (LPA), phosphatidic
acid (PA), and diacylglycerol (DAG) are
present in nonmingling pools.
The committed step in the synthesis
of TAG is glycerol-3-phosphate acyl-
transferase (GPAT), which has tradi-
tionally been believed to exist in everyCell Metabolismcell as two major isoforms, one in the
endoplasmic reticulum (ER) and one
on the mitochondrial outer membrane.
In addition to their subcellular loca-
tions, these GPAT isoforms were
differentiated by their varying suscep-
tibility to inhibition by sulfhydryl
reagents like N-ethylmaleimide and
their different preferences for satu-
rated and unsaturated long-chain fatty
acyl-CoAs. This picture has now been
modified by the recognition that at
least three GPAT isoforms are present
in most tissues. These include two
mitochondrial GPATs (Gonzalez-Baro´
et al., 2007; Lewin et al., 2004) and a
recently cloned ER GPAT (Cao et al.,5, February 2007 ª2007 Elsevier Inc. 87
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GPAT1 and 2 are located on the outer mitochondrial membrane, where they may compete with
carnitine palmitoyltransferase (CPT1) for acyl-CoAs. GPAT3 (as well as other GPATs) is located
on the endoplasmic reticulum. The lysophosphatidic acid (LPA) that these GPAT isoforms synthe-
size is acylated by lysophosphatidic acid acyltransferases (AGPATs) to form phosphatidic acid
(PA), the precursor for phosphatidylinositol (PI), phosphatidylglycerol (PG), and cardiolipin (CL).
Phosphatidic acid phosphohydrolase (PAPase or LIPIN) converts PA to diacylglycerol (DAG),
the precursor of phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylser-
ine (PS), and diacylglycerol acyltransferase (DGAT) acylates DAG to form triacylglycerol (TAG).2006). It has also been noted that the
acyl-CoA:lysophosphatidic acid acyl-
transferase 6 (AGPAT6) is closely
related to GPAT3, implying that it,
too, may have GPAT activity (Beigneux
et al., 2006; Cao et al., 2006). Further-
more, the activities of other desig-
nated AGPAT isoforms have not been
confirmed, and they may also express
GPAT activity. How are we to under-
stand this plethora of enzymes whose
catalytic functions are identical?
GPAT1, the major mitochondrial iso-
form cloned by Sul and colleagues
(Shin et al., 1991), contributes about
10% of total GPAT activity in most tis-
sues and 30%–50% in liver. It is highly
regulated by insulin and SREBP-1c
(Coleman and Lee, 2004), suggesting
an important role in TAG synthesis
during dietary caloric excess. In fact,
the reduced hepatic TAG content and
increased plasma ketone body con-
centrations in Gpat1/ mice suggest
that GPAT1 normally diverts acyl-CoAs
away from b-oxidation and toward
TAG synthesis (Hammond et al., 2005).88 Cell Metabolism 5, February 2007 ª20The second mitochondrial isoform,
GPAT2, is expressed at highest levels
in testis, where its function remains
unexplored. GPAT2 has no acyl-CoA
preference, but, like GPAT1, overex-
pression of GPAT2 in COS-7 cells
results in increased incorporation of
oleate into TAG, but not phospholipid
(Lewin et al., 2004; S. Wang and
R.A.C. unpublished data).
In an important publication in the
November 2006 issue of the Proceed-
ings of the National Academy of
Sciences of the United States of
America, Cao et al. (2006) reported
the first characterization of an ER
GPAT. GPAT3 contains the four motifs
common to glycerolipid acyltrans-
ferases (Coleman and Lee, 2004),
and its mRNA increases dramatically
when 3T3-L1 cells differentiate into
adipocytes. GPAT3 is most highly
expressed in epididymal fat and small
intestine in mouse and in thyroid,
muscle, heart, testis, and kidney in
humans. In both species, GPAT3
expression is notably low in liver, sug-07 Elsevier Inc.gesting the presence of yet another ER
isoform in that tissue. Overexpression
of GPAT3 in HEK293 cells results in
an increase in the incorporation of
[14C]oleate into TAG, even at very low
oleate concentrations.
Thus, each of the GPAT isoforms
reported so far increases the incorpo-
ration of long-chain fatty acid into
TAG, but not phospholipid, and
hepatic TAG stores are diminished in
Gpat1/ mice (Hammond et al.,
2002). None of these GPAT isoforms
appears to initiate the exclusive syn-
thesis of phospholipids; instead, it is
likely that the GPAT isoforms serve to
control the flux of available LPA, PA,
and DAG precursors and that phos-
pholipid synthesis is regulated at the
PA and DAG branchpoints.
In liver and certain adipose depots,
all three GPAT isoforms are expressed
and are presumably translated into
functional proteins. Importantly, gain-
and loss-of-function studies indicate
that their primary role is to synthesize
TAG. But if the synthesis of TAG is their
only function, why, then, are multiple
GPAT isoforms required? Is it possible
that each isoform has an additional
role in regulating the synthesis of the
glycerolipid intermediates that have
been well established in other contexts
as components of intracellular signal-
ing pathways? LPA, the immediate
product of GPAT, interacts with extra-
cellular LPA receptors that control cell
growth and may act intracellularly to
activate PPARg. PA activates several
phosphatases and protein kinases,
and DAG activates the conventional
and novel isoforms of PKC. The estab-
lished model has been that these lipid
intermediates are released from mem-
brane phospholipids after hormones
or cytokines activate phospholipases
C, D, and/or A2. Recent studies, how-
ever, support the novel concept that
signaling pathways involving LPA,
PA, and DAG can also be initiated via
the de novo pathway of TAG synthesis.
It is well known, for example, that ex-
posure to excess fatty acid induces
IRS1 phosphorylation and increases
insulin resistance (Petersen and Shul-
man, 2006). An intimate role for GPAT
in this process can be inferred be-
cause mice lacking GPAT1 are pro-
tected against diet-induced hepatic
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tain less LPA and DAG and show di-
minished activation of PKC3 (Neschen
et al., 2005). In contrast, mice that
overexpress hepatic GPAT1 activity
show pronounced hepatic insulin re-
sistance with elevated LPA and DAG
content (unpublished data).
LPA, PA, and DAG synthesis initi-
ated by each of the GPAT isoforms
constitutes a set of independent sig-
naling pathways that are likely to
respond to the nutrient or caloric con-
tent of the diet and sense changes in
total body and cellular fuel metabo-
lism. A focus on the control of both
expression and acute changes in
enzyme activity of the GPAT isoforms
will enhance our understanding of the
complex metabolic roles played by
nutrients and may identify the signal-ing links between excess tissue TAG
content and insulin resistance.
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